Advanced Protein Technology

Advanced Protein Technology (APT) is a South Korean biotechnology company specializing in the development and large-scale production of high-quality recombinant proteins. Utilizing its proprietary Pichia pastoris yeast expression platform, the company produces a wide range of growth factors and cytokines, including Epidermal Growth Factor (EGF), Fibroblast Growth Factor (bFGF), and Insulin-like Growth Factor (IGF-1). APT serves the pharmaceutical, cosmeceutical, and research industries by providing both catalog products and contract development and manufacturing services (CDMO). The company's technology is designed to achieve high expression levels and bioactivity, supporting applications in wound healing, skin care, and regenerative medicine. With a focus on cost-effective and scalable production, APT has established itself as a key supplier of bioactive proteins for clinical and commercial use globally.